Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 3/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1389428 | 0.89 | CYP11B1 (0.54) | HRH3PGRCYP11B1CYP11B2CYP17A1 | |
| SCHEMBL22127111 | 0.87 | CYP11B1 (0.45) | HRH3PGRCYP11B1CYP11B2CYP17A1 | |
| SCHEMBL22155099 | 0.85 | PGR (0.44) | HRH3PGRCYP11B1CYP11B2CYP17A1 | |
| SCHEMBL744467 | 0.84 | CYP2A6 (0.50) | CYP11B1CYP11B2CYP17A1MAOAMAOB | |
| SCHEMBL1773406 | 0.81 | MAOB (0.64) | CYP11B2MAOAMAOBMMP3CYP2A6 | |
| SCHEMBL4659246 | 0.81 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP2A6 | |
| SCHEMBL15496905 | 0.81 | MAOB (0.64) | CYP11B2MAOAMAOBMMP3CYP2A6 | |
| SCHEMBL16520506 | 0.81 | CYP2A6 (0.62) | CYP11B1CYP11B2CYP2A6 | |
| SCHEMBL16939642 | 0.81 | AHR (0.45) | CYP11B1CYP11B2CYP17A1MAOAMAOB | |
| SCHEMBL3225363 | 0.80 | ESR1 (0.55) | HRH3PGRCYP11B1CYP11B2CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746093-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| US-11746093-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-05 | — | — | US | disclosed |
| US-20230192627-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230192627-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-04 | — | — | US | disclosed |
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-04-05 | — | — | US | disclosed |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-06-25 | — | — | US | disclosed |
| US-20190337872-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2019-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746093-B2 | Nitrogen-containing compound, electronic element, and electronic device | SLC43A1, SLC7A5, L1CAM | HRH3 1531/4885PGR 3470/4885CYP11B1 3598/4885 |
| US-11296282-B2 | Organic compound and organic electroluminescence device using the same | SLCO4C1, EML4, SLCO2A1 | HRH3 3818/4885PGR 3690/4885CYP11B1 1279/4885 |
| US-20190337872-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE | FGF23, SUZ12, RPL24 | HRH3 948/4885PGR 3984/4885CYP11B1 2059/4885 |
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | FGF23, SUZ12, RPL24 | HRH3 948/4885PGR 3984/4885CYP11B1 2059/4885 |
| US-20200203632-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, EML4, SLCO2A1 | HRH3 3818/4885PGR 3690/4885CYP11B1 1279/4885 |
| US-20230192627-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SLC43A1, SLC7A5, L1CAM | HRH3 1531/4885PGR 3470/4885CYP11B1 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.